Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression

The aim of the present study was to investigate the propensity of thiolated chitosan nanoparticles (TCNs) to enhance the nasal delivery of selegiline hydrochloride. TCNs were synthesized by the ionic gelation method. The particle size distribution (PDI), entrapment efficiency (EE), and zeta potentia...

全面介绍

书目详细资料
发表在:Artificial Cells, Nanomedicine and Biotechnology
主要作者: Singh D.; Rashid M.; Hallan S.S.; Mehra N.K.; Prakash A.; Mishra N.
格式: 文件
语言:English
出版: Taylor and Francis Ltd. 2016
在线阅读:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969913328&doi=10.3109%2f21691401.2014.998824&partnerID=40&md5=968df77dacae2cf76c0ad6eedf1adad0
实物特征
总结:The aim of the present study was to investigate the propensity of thiolated chitosan nanoparticles (TCNs) to enhance the nasal delivery of selegiline hydrochloride. TCNs were synthesized by the ionic gelation method. The particle size distribution (PDI), entrapment efficiency (EE), and zeta potential of modified chitosan (CS) nanoparticles were found to be 215 ± 34.71 nm, 70 ± 2.71%, and + 17.06 mV, respectively. The forced swim and the tail suspension tests were used to evaluate the anti-depressant activity, in which elevated immobility time was found to reduce on treatment. TCNs seem to be promising candidates for nose-to-brain delivery in the evaluation of antidepressant activity. © 2015 Informa Healthcare USA, Inc.
ISSN:21691401
DOI:10.3109/21691401.2014.998824